Asset Details
Do you wish to reserve the book?
PBK Expression Is Associated With Prognosis of Patients With Oral Squamous Cell Carcinoma Treated With Radiotherapy: A Retrospective Study
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
PBK Expression Is Associated With Prognosis of Patients With Oral Squamous Cell Carcinoma Treated With Radiotherapy: A Retrospective Study
Do you wish to request the book?
PBK Expression Is Associated With Prognosis of Patients With Oral Squamous Cell Carcinoma Treated With Radiotherapy: A Retrospective Study
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
PBK Expression Is Associated With Prognosis of Patients With Oral Squamous Cell Carcinoma Treated With Radiotherapy: A Retrospective Study
2021
Overview
To investigate the impact of PDZ-binding kinase (PBK) on the clinical outcome of patients with oral squamous cell carcinoma (OSCC) who received radiotherapy.
PBK immunoreactivity of cancer specimens obtained from 179 patients with primary OSCC was analyzed by immunohistochemistry.
High PBK expression in tumor cells tended to be associated with advanced N-stage. The 5-year survival rate was greater for patients with high total PBK expression than in those with low PBK expression. After adjustment, high PBK remained associated with a favorable outcome. In subgroups according to tumor stage, the prognostic role was significant in patients with stage III/IV rather than those with stage I/II disease.
We suggest that PBK expression should be used as an independent prognostic marker for patients with OSCC treated with radiotherapy, especially for those with advanced-stage disease.
Publisher
International Institute of Anticancer Research
Subject
/ Alcohol
/ Biomarkers, Tumor - metabolism
/ Cancer
/ Carcinoma, Squamous Cell - diagnosis
/ Carcinoma, Squamous Cell - mortality
/ Carcinoma, Squamous Cell - pathology
/ Carcinoma, Squamous Cell - radiotherapy
/ Female
/ Gender
/ Humans
/ Kinases
/ Male
/ Mitogen-Activated Protein Kinase Kinases - metabolism
/ Mitogen-Activated Protein Kinase Kinases - physiology
/ Mouth Neoplasms - radiotherapy
/ Oral squamous cell carcinoma
/ Patients
/ Proteins
/ Squamous Cell Carcinoma of Head and Neck - diagnosis
/ Squamous Cell Carcinoma of Head and Neck - mortality
/ Squamous Cell Carcinoma of Head and Neck - pathology
/ Squamous Cell Carcinoma of Head and Neck - radiotherapy
/ Tumors
